For example, APC promoter methylation, SMAD4, and CXCR4 could be a biomarker for the diagnosis and prognosis of CRC.[18] Thus, finding more effective biomarkers for early diagnosis and targeted treatment is absolutely essential in CRC related fields. This evidence concerns the gene APC and colorectal carcinoma.